# Contrast-enhanced Multispectral Optoacoustic Tomography for Non-invasive Assessment of Diabetic Gastroparesis

> **NCT05935852** · NA · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 40 (estimated)

## Conditions studied

- Diabetic Gastroparesis

## Interventions

- **DEVICE:** Multispectral Optoacoustic Tomography (MSOT)

## Key facts

- **NCT ID:** NCT05935852
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-15
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-24
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05935852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05935852, "Contrast-enhanced Multispectral Optoacoustic Tomography for Non-invasive Assessment of Diabetic Gastroparesis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05935852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*